GlaxoSmithKline (GSK) - Shares outstanding

Number of shares outstanding as of December 2025 : 2,017,000,000

According to GlaxoSmithKline's latest financial reports and stock price the company's current number of shares outstanding is 2,017,000,000. At the end of 2025 the company had 2,017,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for GlaxoSmithKline from 2022 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	2.01 B	-1.15%
2024	2.04 B	0.62%
2023	2.02 B	0.55%
2022	2.01 B

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
AstraZeneca AZN	3,102,000,000	53.79%	🇬🇧 UK
Pfizer PFE	5,685,000,000	181.85%	🇺🇸 USA
Merck MRK	2,487,348,810	23.32%	🇺🇸 USA
Novartis NVS	1,926,000,000	-4.51%	🇨🇭 Switzerland
Sanofi SNY	2,436,200,000	20.78%	🇫🇷 France
Teva Pharmaceutical Industries TEVA	1,147,000,000	-43.13%	🇮🇱 Israel
Dynavax Technologies DVAX	117,307,000	-94.18%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for GlaxoSmithKline (GSK)

Number of shares outstanding as of December 2025 : 2,017,000,000